BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4271567)

  • 1. Digestion of fibrin by thrombin.
    Triantaphyllopoulos DC; Chandra S
    Biochim Biophys Acta; 1973 Nov; 328(1):229-32. PubMed ID: 4271567
    [No Abstract]   [Full Text] [Related]  

  • 2. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanism of ancrod anticoagulation. A direct proteolytic effect on fibrin.
    Pizzo SV; Schwartz ML; Hill RL; McKee PA
    J Clin Invest; 1972 Nov; 51(11):2841-50. PubMed ID: 4263497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of human plasminogen by urokinase. Partial characterization of a pre-activation peptide.
    Walther PJ; Steinman HM; Hill RL; McKee PA
    J Biol Chem; 1974 Feb; 249(4):1173-81. PubMed ID: 4273519
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of a low molecular weight form of plasminogen.
    Paoni NF; Castellino FJ
    Biochem Biophys Res Commun; 1975 Jul; 65(2):757-64. PubMed ID: 125089
    [No Abstract]   [Full Text] [Related]  

  • 6. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
    Müllertz S
    Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fate of fibrinopeptides in the reaction between human plasmin and fibrinogen.
    Lahiri B; Shainoff JR
    Biochim Biophys Acta; 1973 Mar; 303(1):161-70. PubMed ID: 4267201
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 9. Zinc modulates thrombin adsorption to fibrin.
    Hopmeier P; Halbmayer M; Fischer M; Marx G
    Thromb Res; 1990 May; 58(3):293-301. PubMed ID: 2353341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrin digestion by thrombin. Comparison with plasmin-digested fibrinogen.
    Kang EP; Triantaphyllopoulos DC
    Biochim Biophys Acta; 1977 Feb; 490(2):430-42. PubMed ID: 138448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The behavior of isotope labelled blood proteins in thrombosis.
    Strachan CJ; Scully MF; Kakkar VV
    Thromb Res; 1974 Feb; 4(2):303-18. PubMed ID: 4831006
    [No Abstract]   [Full Text] [Related]  

  • 12. The lysis of crosslinked human fibrin by plasmin yields initially a single molecular complex, D dimer-E.
    Gaffney PJ; Joe F
    Thromb Res; 1979; 15(5-6):673-87. PubMed ID: 158848
    [No Abstract]   [Full Text] [Related]  

  • 13. Evidence for localization of polymerization sites in fibrinogen.
    Kudryk BJ; Collen D; Woods KR; Blombäck B
    J Biol Chem; 1974 May; 249(10):3322-5. PubMed ID: 4275342
    [No Abstract]   [Full Text] [Related]  

  • 14. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule.
    Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y
    Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fibrinogen B (soluble fibrinogen), its nature and methods of determination].
    Belitser VA
    Lab Delo; 1980; (9):529-32. PubMed ID: 6157920
    [No Abstract]   [Full Text] [Related]  

  • 16. Human fibrinogen heterogeneities. I. Structural and related studies of plasma fibrinogens which are high solubility catabolic intermediates.
    Mosesson MW; Finlayson JS; Umfleet RA; Galanakis D
    J Biol Chem; 1972 Aug; 247(16):5210-9. PubMed ID: 4262568
    [No Abstract]   [Full Text] [Related]  

  • 17. Release of fibrinopeptides from fibrinolytic fibrinogen fragment E.
    Peyer A; Straub PW
    Thromb Diath Haemorrh; 1973 May; 29(2):300-12. PubMed ID: 4271587
    [No Abstract]   [Full Text] [Related]  

  • 18. Role of plasmin in the degradation of the stroma-derived fibrin in human ovarian carcinoma.
    Wilhelm O; Hafter R; Henschen A; Schmitt M; Graeff H
    Blood; 1990 Apr; 75(8):1673-8. PubMed ID: 2139349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Investigations of fibrin clots formation under the effect of thrombin and ancystron].
    Savchuk OM; Chernyshov VI; Volkov HL
    Ukr Biokhim Zh (1999); 2004; 76(3):122-5. PubMed ID: 19621750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.